A new study has found that pregnant women with COVID-19 do not pass the virus to newborns, however, they may pass fewer-than-expected antibodies to newborns.
Dec. 22, 2020 • ~3 min
covid-19 health-medicine sars-cov-2 pregnant-women
The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.
Oct. 6, 2020 • ~5 min
covid-19 health-medicine brigham-and-womens-hospital broad-institute sars-cov-2 covid-tests testboston
“Viral history” tool VirScan offers new insights into antibody response to SARS-CoV-2.
Sept. 29, 2020 • ~6 min
science-technology covid-19 coronavirus pandemic harvard-medical-school brigham-and-womens-hospital sars-cov-2
A new study has found that children infected with the virus that causes COVID-19 were shown to have a significantly higher level of virus in their airways than hospitalized adults in ICUs for COVID-19 treatment.
Aug. 20, 2020 • ~8 min
children covid-19 basic-research health-medicine massachusetts-general-hospital sars-cov-2
A single-shot COVID-19 vaccine is being developed by scientists led by a Beth Israel Deaconess Medical Center immunologist.
July 30, 2020 • ~5 min
covid-19 harvard-medical-school mit health-medicine beth-israel-deaconess-medical-center sars-cov-2 and-harvard adenovirus-serotype-26 johnson-johnson ragon-institute-of-massachusetts-general-hospital
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
May 20, 2020 • ~8 min
covid-19 coronavirus harvard-medical-school health-medicine ragon-institute vaccine sars-cov-2 dan-h-barouch re-infection
An outpouring of volunteers and equipment from the Harvard medical community have helped a Harvard hospital testing lab meet COVID’s challenge.
May 11, 2020 • ~9 min
covid-19 health-medicine alvin-powell beth-israel-deaconess-medical-center sars-cov-2 jeffrey-saffitz testing annie-cheng erin-duffy james-kirby jihoon-lim laboratory-technician molecular-diagnostics-lab pathology volunteer
Harvard researchers are turning to two common cold viruses to learn lessons about how the coronavirus that causes COVID-19 might behave in the coming months.
April 14, 2020 • ~6 min
covid-19 pandemic health-medicine sars-cov-2 cold-virus
Further research and development on a class of molecules called bisphosphonates might turbocharge a vaccine against SARS-CoV-2, the novel coronavirus, and help bring immunity to huge populations more quickly.
April 9, 2020 • ~16 min
science-technology covid-19 basic-research sars-cov-2 harvard-office-of-technology-development mit-and-harvard ragon-institute-of-mgh uli-von-andrian